Skip to main content
Wonbiogen Co.,Ltd. logo

Wonbiogen Co.,Ltd. — Investor Relations & Filings

Ticker · 307280 ISIN · KR7307280008 KO Manufacturing
Open in API
Filings indexed 203 across all filing types
Latest filing 2026-05-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 307280

About Wonbiogen Co.,Ltd.

http://www.wonbiogen.co.kr/eng/main/ind…

Wonbiogen Co., Ltd. is a company that develops, manufactures, and sells specialized medical devices and supplies. It focuses on the research and development of new medical bio-substances and highly biocompatible medical macromolecules to create advanced wound care solutions. The company's core product offerings consist of specialized wound dressings, including polyurethane foams, soft silicone adhesive dressings, and hydrocolloid spot patches. Its portfolio is marketed under brand names such as Medisorb and Renoderm, which are designed for various applications in wound protection and management.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is a 분기보고서 (quarterly report) covering the period January 1, 2026 to March 31, 2026 (9th term) for (주)원바이오젠. It contains detailed business descriptions, historical data, corporate structure, capital changes, and substantive financial metrics and analysis. This aligns exactly with a comprehensive interim/quarterly financial report rather than a brief earnings release or simple announcement. Q1 2026
2026-05-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” and details the results of the Annual General Meeting (AGM), including approval of financial statements, dividend resolutions, director/auditor elections, and vote percentages for each agenda item. This corresponds exactly to a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is a standalone audit report (“감사보고서”) for the consolidated financial statements of One Biogen Co., Ltd. and its subsidiaries, including the auditor’s opinion, scope, responsibilities, and the full set of audited consolidated financial statements and notes. This matches the definition of an Audit Report / Information (AR). FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a submission of a standalone audit report (“감사보고서 제출”) containing the auditor’s opinion, audit results on the consolidated and separate financial statements for the fiscal year ending 2025-12-31, auditor’s name, and other audit-related disclosures. There is no indication this is a full annual report or merely an announcement; rather, it is the audit report itself. Therefore, it matches the Audit Report / Information category. FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Wonbiogen Co., Ltd. It includes the meeting agenda, details on voting procedures (including electronic voting), and financial statements (balance sheet, income statement, etc.) as part of the business report for the 8th fiscal year. This type of document is a standard proxy statement/information circular provided to shareholders to solicit votes for the upcoming Annual General Meeting. In the provided classification schema, this fits best under 'Proxy Solicitation & Information Statement'.
2026-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) issued by Wonbiogen. It outlines the date, location, agenda items (such as financial statement approval, director/auditor appointments, and dividend approval), and details regarding electronic voting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.